NME8

Across TCGA pan-cancer cohorts, NME8 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated NME8 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in brain lower grade glioma (LGG), where higher NME8 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated NME8 expression acts as an unfavorable survival marker.

LGG, LUAD, and UCEC are the cancer types where NME8 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Median	All	0.163	0.896	<.001	12	view →
LUAD	DFS	Median	II,III,IV	0.178	0.721	.008	9	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
HNSC	DFS	Median	IV	0.187	0.669	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

NME8–LGG (OS)

Open the LGG breakdown →